Maternal inflammation during pregnancy and risk of immune-mediated diseases in birth cohorts

In the last half of the 20th century, rates of immune-mediated diseases have increased worldwide, hinting at changes in our environment as a possible common risk factor for disease. In this webinar, Dr. Jonathan Thorsen, senior researcher at COPSAC, will detail The HEDIMED project, a collaboration which aims to accelerate disease understanding and prevention by identifying shared determinants of immune-mediated diseases.

Dr. Thorsen will further highlight a study which aims to identify perinatal immune markers for childhood immune-mediated diseases across four European birth cohorts (COPSAC2010, PREDICTA, GDME, and DIPP). He will also discuss how the Olink Target96 Inflammation platform can be used to discover patterns in immune mediators linked with disease endpoints in childhood.

Key learning objectives

• Understand how protein biomarkers from perinatal blood samples were utilized to study early-life determinants of immune-related diseases
• Identify associations of immune mediators with disease endpoints in childhood
• Explore strategies to identify perinatal immune markers for childhood immune-mediated diseases across four European birth cohorts

Who should attend?

• Researchers and clinical scientists in academia, biotech and pharma, working within immunology, celiac disease, type 1 diabetes, asthma, allergy, and other immune-related diseases (inflammation therapeutics) within children/pediatrics.

Certificate of attendance
All webinar participants can request a certificate of attendance, including a learning outcomes summary, for continuing education purposes.